You are here

B cell lymphoma

Calithera buys itself a plan B

EP Vantage

Tue, 10/19/21 - 10:43 am

Calithera Biosciences

B cell lymphoma

Bristol Myers' CAR-T Breyanzi busts out a win in earlier-line lymphoma, potentially cracking open an expanded market

Endpoints

Thu, 06/10/21 - 10:50 am

Bristol-Myers Squibb

B cell lymphoma

Kite Receives Positive Opinion from CHMP for Yescarta in Lymphoma

Fri, 06/29/18 - 09:42 am

B cell lymphoma

Idera Pharmaceuticals Presents a Promising Opportunity

Wall St Cheat Sheet

Thu, 12/26/13 - 02:45 pm

Idera Pharmaceuticals

autoimmune disease

B cell lymphoma